| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.736 | 19.573 | 38.746 | 50.417 | 54.361 | 43.485 | 42.203 | 49.339 | 55.798 | 56.997 |
| Total Income - EUR | 4.736 | 19.573 | 38.746 | 50.624 | 60.076 | 44.560 | 42.670 | 50.157 | 57.994 | 56.997 |
| Total Expenses - EUR | 3.244 | 18.768 | 29.650 | 43.606 | 46.226 | 34.198 | 24.596 | 35.231 | 44.134 | 49.273 |
| Gross Profit/Loss - EUR | 1.492 | 805 | 9.096 | 7.018 | 13.850 | 10.362 | 18.074 | 14.926 | 13.860 | 7.724 |
| Net Profit/Loss - EUR | 1.350 | 218 | 8.173 | 6.515 | 13.307 | 10.075 | 18.018 | 14.132 | 13.281 | 7.260 |
| Employees | 0 | 0 | 1 | 3 | 4 | 1 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Cipramex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 12.650 | 8.823 | 5.114 | 19.865 | 14.796 | 12.235 | 11.976 | 7.979 | 6.022 |
| Current Assets | 1.392 | 3.038 | 2.336 | 6.810 | 18.765 | 31.454 | 48.645 | 44.622 | 11.312 | 3.646 |
| Inventories | 1.068 | 2.036 | 977 | 25 | 0 | 0 | 79 | 246 | 1.082 | 0 |
| Receivables | 0 | 712 | 0 | 0 | 806 | 0 | 0 | 1 | 8.087 | 66 |
| Cash | 324 | 290 | 1.359 | 6.785 | 17.959 | 31.454 | 48.566 | 44.375 | 2.143 | 3.581 |
| Shareholders Funds | -5.311 | -5.028 | 3.231 | 9.686 | 22.806 | 32.451 | 49.726 | 48.238 | 13.358 | 7.352 |
| Social Capital | 45 | 56 | 55 | 54 | 53 | 54 | 53 | 53 | 53 | 52 |
| Debts | 6.703 | 20.716 | 7.928 | 2.238 | 15.824 | 13.799 | 11.154 | 8.360 | 5.933 | 2.316 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4932 - 4932" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Cipramex Srl